BioNTech SE (BNTX) Depreciation & Amortization (CF) (2018 - 2021)

BioNTech SE (BNTX) has 4 years of Depreciation & Amortization (CF) data on file, last reported at $15.7 million in Q1 2021.

• For the quarter ending Q1 2021, Depreciation & Amortization (CF) rose 65.17% year-over-year to $15.7 million; the trailing twelve-month figure through Dec 2021 stood at $15.7 million (up 65.17% YoY), and the FY2020 full-year result was $44236.9, up 16.53% from the prior year.
• Depreciation & Amortization (CF) climbed to $15.7 million in Q1 2021, from $9.5 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $15.7 million in Q1 2021 to a low of -$26.6 million in Q4 2019.
• A 4-year average of -$4.3 million and a median of -$3.1 million in 2018 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) tumbled 69.8% in 2019 and soared 65.17% in 2021, its largest moves.
• Tracing BNTX's Depreciation & Amortization (CF) over 4 years: stood at -$15.7 million in 2018, then plunged by 69.8% to -$26.6 million in 2019, then surged by 135.66% to $9.5 million in 2020, then soared by 65.17% to $15.7 million in 2021.
• Business Quant data shows BNTX's Depreciation & Amortization (CF) at $15.7 million in Q1 2021, $9.5 million in Q1 2020, and -$26.6 million in Q4 2019.